Trevi Therapeutics Inc
Officers & Directors
1. Jennifer Good - President and Chief Executive Officer, Director
Jennifer Good previously served as President and CEO of Pliant Therapeutics, a clinical stage biopharmaceutical company focused on fibrosis. Before that, she worked at Genentech for over two decades, where she held various leadership positions.
2. Michael Heffernan - Director
3. Christopher Galletta - Controller
4. Dominick Colangelo - Director
5. David Meeker, M.D. - Chairman of the Board
6. Lisa Delfini - Chief Financial Officer
7. Anne VanLent - Director
8. James V. Cassella, Ph.D. - Director
9. Edward Mathers - Director
10. Dr. Rebecca C. Keeler - Chief Medical Officer and Senior Vice President of Clinical Development
Dr. Keeler has over 20 years of experience in clinical research and drug development. Prior to joining Trevi Therapeutics, she held numerous clinical development and medical affairs positions at GSK, including as Senior Director of Clinical Development within the Immunology department.
11. Dr. Michael Metzger - Chief Operating Officer
Dr. Metzger has more than 20 years of experience in the biopharmaceutical industry, primarily focused on developing and commercializing innovative therapies for rare diseases. Prior to joining Trevi, he served as Chief Medical Officer at BioCryst Pharmaceuticals, and held various leadership positions at Shire, including as Head of Global Medical Affairs for Rare Diseases.
12. Dr. Eric J. Mosbrooker - Chief Financial Officer
Dr. Mosbrooker has over 20 years of experience in the biopharmaceutical industry, and prior to joining Trevi, he served as CFO and COO of Ocular Therapeutix. He has also held various finance and operational leadership roles at Cubist Pharmaceuticals, Ironwood Pharmaceuticals, and Wyeth Pharmaceuticals.
13. Dr. Barbara S. Slusher - Chairman of the Board
Dr. Slusher is an experienced biotech executive and entrepreneur who has founded several successful companies, including NeuX Technologies, Next Cure, and Cerecor. Additionally, she has held various leadership positions in academia, including at Johns Hopkins University School of Medicine.,
Trevi Therapeutics Inc currently has 34 employees.
|
